4209:
Primary Immune Deficiency: Quality of Life and New Therapies
Monday, March 5, 2018: 9:45 AM-10:45 AM
Convention Center, South Concourse, Level 1, South Hall A2
Poster Session
0.00 CME/CE
840
Determinants of health related quality of life (HRQoL) in adult patients with hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE)
Marina Lluncor, M.D. Donatella Lamacchia, M.D. Adriana Hernanz, MS Maria Pedrosa, M.D., Ph.D. Ana Alvez, M.D. Rosario Cabañas, M.D., Ph.D. Nieves Prior, M.D., Ph.D. Teresa Caballero, MD PhD
842
Real-world experience of a cohort of previously untreated PI patients on SCIG
Christopher Scalchunes, MPA Rajiv Mallick, PhD Jacob M. Romano, PharmD, RPh, BS Tiffany S. Henderson, PHD
843
Prevalence And Outcomes Of Primary Immunodeficiency In Hospitalized Children In The United States
Zachary Rubin, MD Andrea A. Pappalardo, MD Alan Schwartz, PhD James W Antoon, MD, PhD
845
Infusion Parameters and Adverse Events in Patients With Primary Immunodeficiency Diseases Who Switched to Subcutaneous Human Immune Globulin 20% (Ig20Gly) From Intravenous or Subcutaneous Immune Globulin
Iftikhar Hussain Kenneth Paris Amy Darter Lisa J. Kobrynski, MD, MPH Todd Berner Barbara McCoy Ping Wang Christopher J. Rabbat Leman Yel
846
Onboarding Experience of Pediatric Patients With Primary Immunodeficiency Diseases With Subcutaneous Human Immune Globulin 20% (Ig20Gly)
Kenneth Paris Iftikhar Hussain Sudhir Gupta Ping Wang Barbara McCoy Christopher J. Rabbat Leman Yel
847
Patient-reported experience on training associated with subcutaneous immunoglobulin (SCIG) therapy self-administration
Tiffany S. Henderson, PHD Rajiv Mallick, PhD Jacob M. Romano Christopher Scalchunes, MPA
See more of: Abstracts